- Home
- GOVX vs WNW Comparison
GOVX vs WNW Comparison
Compare GOVX & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOVX | WNW |
|---|---|---|
| Founded | 2001 | 2015 |
| Country | United States | China |
| Employees | 17 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 3.6M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | GOVX | WNW |
|---|---|---|
| Price | $1.10 | $3.37 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | 76.2K | ★ 4.0M |
| Earning Date | 04-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.14 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.12 | $0.05 |
| 52 Week High | $4.40 | $13.52 |
Technical Indicators
Market Signals| Indicator | GOVX | WNW |
|---|---|---|
| Relative Strength Index (RSI) | 32.94 | 53.63 |
| Support Level | $0.64 | $1.40 |
| Resistance Level | $4.40 | $5.43 |
| Average True Range (ATR) | 0.08 | 0.81 |
| MACD | 0.00 | -0.09 |
| Stochastic Oscillator | 0.00 | 14.82 |
Price Performance
Historical ComparisonAbout GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.